Ewing sarcoma sample zccs227 showed differential sensitivity to a number of chemotherapeutic agents including doxorubicin, irinotecan and vincristine as well as targeted agents affecting PI3K pathway, receptor tyrosine kinase (ALK) and cell cycle (AURKA) signalling pathways (Fig. 6F). Here, NTRK1 is linked to Ewing sarcoma.